US Patent Issued to ORYZON GENOMICS on July 7 for "Methods of treating borderline personality disorder" (Spanish, Portuguese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,044, issued on July 7, was assigned to ORYZON GENOMICS S.A. (Madrid).

"Methods of treating borderline personality disorder" was invented by Carlos Manuel Buesa Arjol (Castelldefels, Spain), Roger Alan Bullock (Portimao, Portugal) and Jose Antonio Ramos Quiroga (Barcelona, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for treating borderline personality disorder using KDMIA inhibitors, particularly vafidemstat."

The patent was filed on March 20, 2020, under Application No. 17/439,575.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Se...